KNEAT.COM INC (KSI.CA) Stock News
TSX:KSI - Toronto Stock Exchange - CA4988241010 - Common Stock - Currency: CAD
KSI.CA Latest News, Press Relases and Analysis
Global Diagnostics Leader Selects Kneat
Global Diagnostics Leader Selects Kneat
Global leader in clinical diagnostics selects Kneat for validation. ...
Kneat Announces Record Revenue for First Quarter 2025
Kneat Announces Record Revenue for First Quarter 2025
kneat.com's Q1 shows continued strong growth and progress toward sustained profitability, ending the quarter with record revenue and a strong cash...
Kneat Expands Executive Leadership Team
Kneat expands leadership team; adds Donal O'Sullivan as Chief Product Officer....
ALTEN Selects Kneat to Digitize Validation
ALTEN selects Kneat to digitize validation for itself and its customers....
Kneat Announces Results of Voting at Annual General Meeting
Kneat announces voting results of 2024 Annual General Meeting of shareholders....
Kneat Expands Executive Leadership Team
Co-founder Kevin Fitzgerald Becomes Chief Innovation Officer as Donal O’Sullivan Joins as Chief Product Officer
Kneat to Announce 2025 First-Quarter Financial Results May 7, 2025
Kneat to Announce 2025 First-Quarter Financial Results May 7, 2025
kneat.com to announce its first-quarter 2025 financial results on May 7, 2025....
Global Generics Pharma Leader Selects Kneat
Kneat's win of a global generics pharma leader showcases the versatility of its platform, which can be leveraged to deliver additional adjacent functions....
Kneat to Announce 2024 First Quarter Financial Results May 8, 2024
Global Generics Pharma Leader Selects Kneat
Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2024
Kneat achieves record revenue and gross profit in Q4 2024, with ARR growing 60% to $59.7 million....
Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2024
Kneat to Announce 2024 Fourth-Quarter and Full-Year Financial Results February 26, 2025
Kneat will announce 2024 fourth-quarter and full-year financial results after market close on February 26, 2025....
Kneat to Announce 2024 Fourth-Quarter and Full-Year Financial Results February 26, 2025
Global Consumer Products Leader Selects Kneat to Digitize Validation
A large consumer packaged goods producer signed an agreement with Kneat to digitize validation in its life science division. ...
Global Consumer Products Leader Selects Kneat to Digitize Validation
Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation
Leading European global therapeutics company more than 20,000 people selects Kneat to digitize its validation processes....
Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation
Global Medical Device Manufacturer Selects Kneat to Digitize Computer System Validation
Medical devices and healthcare therapies maker signs 3-year Master Services Agreement with Kneat to streamline its computer systems validation processes....
Global Medical Device Manufacturer Selects Kneat to Digitize Computer System Validation
ALTEN Selects Kneat to Digitize Validation
Kneat Achieves Record Results in Growth and Profitability
Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively, ...
Kneat Achieves Record Results in Growth and Profitability
Third-quarter Revenue and Gross Profit Growth Accelerate to 52% and 78% Respectively
Global Medical Devices Manufacturer Selects Kneat to Digitize Validation
Kneat signs a global and diverse medical devices manufacturer for digital validation....
Global Medical Devices Manufacturer Selects Kneat to Digitize Validation
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024, and Host an Earnings Call on November 7...
Kneat Announces Closing of $35.6 Million Bought Deal
Kneat closed its previously announced bought deal, issuing 7,500,000 shares for gross proceeds to the Company of $35.6 million. ...
Global Pharma Selects Kneat to Digitize Computer System Validation
Another global pharmaceutical company selects Kneat to digitize its validation processes....
Kneat Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus
Kneat filed a final short-form prospectus, which qualifies the distribution of common shares in connection with its previously announced bought deal....
How to Analyze a Balance Sheet
Real-life examples to help investors make sense of this critical document.
Kneat Announces Record Revenue for Second Quarter 2024
Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%...
Kneat and Körber Pharma Consulting Partner to Accelerate Life Sciences Digitalization
Pharma technology leader enhances its portfolio by becoming a certified Kneat reseller, implementation and managed services partner ...
Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Small-Cap Growth Virtual Investor Conference Agenda Announced for June 13th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
Kneat to Present at the Small-Cap Growth Virtual Investor Conference June 13th
Company invites individual and institutional investors, as well as advisors and analysts, to attend in person or online at VirtualInvestorConferences.com
Kneat Announces Record Revenue for First Quarter 2024
Kneat maintains 35% year-over-year revenue growth to surpass $10 million quarterly revenue mark, as annual recurring revenue growth accelerates to 57%....